NEW DELHI, March 28, 2026 /PRNewswire/ -- According to the in-depth research report published by MarkNtel Advisors, the United Kingdom Soft Gelatin Capsules Market is expected to grow at a CAGR of 5.8% during 2026–2032. The market growth is primarily driven by the increasing demand for nutraceutical products, rising consumer inclination toward preventive healthcare, and the growing preference for easy-to-consume dosage forms. Additionally, advancements in softgel formulation technologies, along with the expansion of contract manufacturing capabilities, are further supporting market expansion across the United Kingdom.

United Kingdom Soft Gelatin Capsules Market Key Takeaways

• The United Kingdom Soft Gelatin Capsules Market was valued at around USD 275 million in 2025 and is projected to grow from USD 290.95 million in 2026 to approximately USD 408.07 million by 2032, reflecting steady growth driven by increasing health awareness and demand for nutraceutical supplements.
• By type, Gelatin Soft Capsules held a dominant share of approximately 78% in 2026, supported by their widespread use, cost-effectiveness, and compatibility with a wide range of formulations.
• By application, the Nutraceutical segment accounted for around 51% market share in 2026, driven by rising consumer focus on wellness, dietary supplements, and preventive healthcare practices.
• The presence of leading global and regional manufacturers is intensifying competition, with continuous innovation in capsule formulations, delivery mechanisms, and plant-based alternatives.

Download a FREE PDF Sample of the Report

https://www.marknteladvisors.com/query/request-sample/united-kingdom-soft-gelatin-capsules-market-report.html (Discover the market potential, emerging technologies, and key industry insights.)

Growth Catalysts Transforming the United Kingdom Soft Gelatin Capsules Market

• Rising Demand for Nutraceuticals and Preventive Healthcare

A key factor driving market growth is the increasing consumer shift toward nutraceutical products aimed at maintaining overall health and preventing chronic diseases. Consumers are increasingly adopting dietary supplements such as vitamins, omega-3 fatty acids, and herbal formulations, many of which are commonly delivered in softgel form due to their superior bioavailability and ease of consumption.

This trend is particularly prominent among aging populations and health-conscious individuals seeking convenient and effective supplementation solutions. As a result, nutraceutical applications continue to drive substantial demand for soft gelatin capsules across the United Kingdom.

• Growing Preference for Easy-to-Consume and High-Bioavailability Dosage Forms

Soft gelatin capsules offer several advantages, including improved absorption, precise dosing, and ease of swallowing, making them a preferred choice over traditional tablets and hard capsules. These benefits are encouraging both pharmaceutical and nutraceutical manufacturers to increasingly adopt softgel formats for a wide range of formulations.

Moreover, advancements in encapsulation technologies are enabling the development of complex formulations, including liquid, semi-solid, and lipid-based ingredients, further enhancing product efficacy and consumer acceptance.

• Expansion of Contract Manufacturing and Innovation in Plant-Based Capsules

Another significant growth driver is the expanding role of contract manufacturing organizations (CMOs/CDMOs) in the market. These entities provide scalable production capabilities, formulation expertise, and cost efficiencies, allowing companies to focus on product development and branding.

Additionally, the growing demand for vegetarian and plant-based soft capsules is encouraging manufacturers to invest in non-gelatin alternatives. This shift aligns with evolving consumer preferences toward clean-label, vegan, and sustainable products, thereby opening new growth avenues within the market.

Key Challenges Affecting Market Growth

• Regulatory Compliance and Raw Material Constraints

Despite favorable growth trends, the market faces challenges related to stringent regulatory requirements governing pharmaceutical and nutraceutical products. Compliance with quality standards, labeling regulations, and ingredient approvals can increase operational complexities for manufacturers.

Furthermore, fluctuations in the availability and pricing of raw materials, particularly animal-derived gelatin, may impact production costs. These factors could pose challenges for manufacturers, although ongoing innovation in plant-based alternatives is expected to mitigate some of these concerns over time.

Market Analysis by Type and Application

By type, gelatin soft capsules dominated the United Kingdom Soft Gelatin Capsules Market, capturing approximately 78% share in 2026. This dominance is primarily attributed to their long-established usage, cost efficiency, and high compatibility with a broad range of pharmaceutical and nutraceutical formulations. Their ability to encapsulate liquid and semi-solid ingredients with enhanced stability further strengthens their adoption across manufacturers. In addition, well-established production infrastructure and regulatory familiarity continue to support their widespread utilization. Meanwhile, non-gelatin (vegetarian) capsules are gradually gaining momentum, driven by increasing consumer preference for vegan, clean-label, and sustainable products, thereby creating new growth opportunities within the segment.

By application, the nutraceutical segment held the largest share of around 51% in 2026, driven by the growing consumer focus on preventive healthcare and overall wellness. Increasing consumption of dietary supplements, including vitamins, minerals, and omega-3 formulations, continues to fuel demand for softgel delivery systems due to their superior bioavailability and ease of consumption. Furthermore, rising health awareness among aging populations and fitness-conscious individuals is reinforcing segment growth. In contrast, pharmaceutical applications maintain steady demand supported by prescription-based usage and clinical reliability. At the same time, cosmeceuticals are emerging as a niche yet promising segment, propelled by the increasing popularity of beauty-from-within and skin health supplements.

View Full Report (All Data, In One Place) https://www.marknteladvisors.com/research-library/united-kingdom-soft-gelatin-capsules-market-report.html (Explore in-depth analyses, technology trends, and investment opportunities.)

Competitive Landscape of the United Kingdom Soft Gelatin Capsules Market

The United Kingdom Soft Gelatin Capsules Market is highly competitive, with the presence of both global and regional players focusing on product innovation, formulation expertise, and contract manufacturing capabilities. Key companies operating in the market include:

• EuroCaps Ltd.
• Catalent Inc.
• Aenova Group
• Lonza Group Ltd.
• Soft Gel Technologies Inc.
• Captek Softgel International
• INW Bee Health Ltd.
• Supplement Factory Ltd.
• HTC Health Ltd.
• Nutra Direct Ltd.
• NextPharma
• Strides Pharma Science Ltd.
• Cloverty Ltd.
• Others

United Kingdom Soft Gelatin Capsules Market Scope

By Type: Gelatin Soft Capsules, Non-Gelatin (Vegetarian) Soft Capsules
By Application: Pharmaceutical, Nutraceutical, Cosmeceutical
By End User: Pharmaceutical Companies, Nutraceutical Companies, Contract Manufacturing Organizations (CMOs/CDMOs)
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Browse More Reports

Global Softgel Capsules Market: The Global Softgel Capsules Market size is valued at around USD 1.23 billion in 2023 and is estimated to grow at a CAGR of about 7.24% during the forecast period, i.e., 2024-30.

Global Capsule Endoscopy Market: The Global Capsule Endoscopy Market is projected to grow at a CAGR of around 10.42% during the forecast period, i.e., 2022-27.

Peru Healthcare Market: The Peru Healthcare Market size was valued at USD 26.52 billion in 2025 and is projected to grow from USD 28.25 billion in 2026 to USD 41.24 billion by 2032, exhibiting a CAGR of 6.51% during the forecast period, i.e., 2026-32.

China Healthcare Market: The China Healthcare Market size was valued at USD 1.42 trillion in 2025 and is projected to grow from USD 1.55 trillion in 2026 to USD 2.62 trillion by 2032, exhibiting a CAGR of 9.14 % during the forecast period, i.e, 2026-32.

UAE Healthcare Market: The UAE Healthcare Market size was valued at USD 3.4 billion in 2025 and is projected to grow from USD 3.74 billion in 2026 to USD 6.63 billion by 2032, exhibiting a CAGR of 10% during the forecast period, i.e., 2026-32.

Saudi Arabia Healthcare Market: The Saudi Arabia Healthcare Market size was valued at USD 139 billion in 2025 and is projected to grow from USD 152 billion in 2026 to USD 259 billion by 2032, exhibiting a CAGR of 9.35% during the forecast period. i.e., 2026-32.

Kuwait Healthcare Market: The Kuwait Healthcare Market size was valued at USD 6.67 billion in 2025 and is projected to grow from USD 7.23 billion in 2026 to USD 12.24 billion by 2032, exhibiting a CAGR of 9.17 % during the forecast period, i.e., 2026-32.

Oman Healthcare Market: The Oman Healthcare Market size was valued at USD 5.10 billion in 2025 and is projected to grow from USD 5.31 billion in 2026 to USD 6.74 billion by 2032, exhibiting a CAGR of 4.05% during the forecast period, i.e., 2026-32.

About MarkNtel Advisors

MarkNtel Advisors is a leading market research and consulting firm dedicated to delivering reliable, data-driven insights across a wide range of global industries. The firm combines extensive primary research, including interviews with industry experts and key stakeholders, with thoroughly validated secondary data to ensure accurate and credible market intelligence. Backed by deep sector expertise and a team of experienced analysts, MarkNtel Advisors provides strategic insights that help businesses, investors, and decision-makers understand evolving market dynamics. Through comprehensive research methodologies and forward-looking analysis, the company supports organizations in identifying growth opportunities and making informed decisions in increasingly competitive and rapidly changing market environments.

Contact Us:
MarkNtel Advisors
Office No.109, H-159, Sector 63, Noida, Uttar Pradesh – 201301, India
Contact No: +91 87199 99009
Email: sales@marknteladvisors.com
Website: marknteladvisors.com

Logo: https://mma.prnewswire.com/media/2687299/MarkNtel_Advisors_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/uk-soft-gelatin-capsules-market-to-reach-usd-408-07-million-by-2032--growing-at-a-cagr-of-5-8-during-20262032--markntel-advisors-302727596.html

SOURCE MarkNtel Advisors